Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data
- PMID: 31353194
- DOI: 10.1016/S2213-8587(19)30189-5
Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data
Abstract
Background: The benefits and risks of testosterone treatment for women with diminished sexual wellbeing remain controversial. We did a systematic review and meta-analysis to assess potential benefits and risks of testosterone for women.
Methods: We searched MEDLINE, Embase, the Cochrane Central Register of Controlled Trials, and Web of Science for blinded, randomised controlled trials of testosterone treatment of at least 12 weeks' duration completed between Jan 1, 1990, and Dec 10, 2018. We also searched drug registration applications to the European Medicine Agency and the US Food and Drug Administration to identify any unpublished data. Primary outcomes were the effects of testosterone on sexual function, cardiometabolic variables, cognitive measures, and musculoskeletal health. This study is registered with the International Prospective Register of Systematic Reviews (PROSPERO), number CRD42018104073.
Findings: Our search strategy retrieved 46 reports of 36 randomised controlled trials comprising 8480 participants. Our meta-analysis showed that, compared with placebo or a comparator (eg, oestrogen, with or without progestogen), testosterone significantly increased sexual function, including satisfactory sexual event frequency (mean difference 0·85, 95% CI 0·52 to 1·18), sexual desire (standardised mean difference 0·36, 95% CI 0·22 to 0·50), pleasure (mean difference 6·86, 95% CI 5·19 to 8·52), arousal (standardised mean difference 0·28, 95% CI 0·21 to 0·35), orgasm (standardised mean difference 0·25, 95% CI 0·18 to 0·32), responsiveness (standardised mean difference 0·28, 95% CI 0·21 to 0·35), and self-image (mean difference 5·64, 95% CI 4·03 to 7·26), and reduced sexual concerns (mean difference 8·99, 95% CI 6·90 to 11·08) and distress (standardised mean difference -0·27, 95% CI -0·36 to -0·17) in postmenopausal women. A significant rise in the amount of LDL-cholesterol, and reductions in the amounts of total cholesterol, HDL-cholesterol, and triglycerides, were seen with testosterone administered orally, but not when administered non-orally (eg, by transdermal patch or cream). An overall increase in weight was recorded with testosterone treatment. No effects of testosterone were reported for body composition, musculoskeletal variables, or cognitive measures, although the number of women who contributed data for these outcomes was small. Testosterone was associated with a significantly greater likelihood of reporting acne and hair growth, but no serious adverse events were recorded.
Interpretation: Testosterone is effective for postmenopausal women with low sexual desire causing distress, with administration via non-oral routes (eg, transdermal application) preferred because of a neutral lipid profile. The effects of testosterone on individual wellbeing and musculoskeletal and cognitive health, as well as long-term safety, warrant further investigation.
Funding: Australian National Health and Medical Research Council.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Comment in
-
Testosterone for women: green light for sex, amber light for health?Lancet Diabetes Endocrinol. 2019 Oct;7(10):738-739. doi: 10.1016/S2213-8587(19)30251-7. Epub 2019 Jul 25. Lancet Diabetes Endocrinol. 2019. PMID: 31353193 No abstract available.
Similar articles
-
Testosterone therapy and other treatment modalities for female sexual dysfunction.Curr Opin Urol. 2020 May;30(3):309-316. doi: 10.1097/MOU.0000000000000759. Curr Opin Urol. 2020. PMID: 32205812 Review.
-
Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.Menopause. 2006 May-Jun;13(3):387-96. doi: 10.1097/01.gme.0000179049.08371.c7. Menopause. 2006. PMID: 16735935 Clinical Trial.
-
Oestrogen versus androgen in hormone-replacement therapy for complete androgen insensitivity syndrome: a multicentre, randomised, double-dummy, double-blind crossover trial.Lancet Diabetes Endocrinol. 2018 Oct;6(10):771-780. doi: 10.1016/S2213-8587(18)30197-9. Epub 2018 Jul 31. Lancet Diabetes Endocrinol. 2018. PMID: 30075954 Clinical Trial.
-
The current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.J Sex Med. 2008 Sep 2;5 Suppl 4:182-93; quiz 193. doi: 10.1111/j.1743-6109.2008.00961.x. J Sex Med. 2008. PMID: 18783534 Review.
-
Testosterone for low libido in postmenopausal women not taking estrogen.N Engl J Med. 2008 Nov 6;359(19):2005-17. doi: 10.1056/NEJMoa0707302. N Engl J Med. 2008. PMID: 18987368 Clinical Trial.
Cited by
-
Summary of the 2023 Thai Menopause Society Clinical Practice Guideline on Menopausal Hormone Therapy.J Menopausal Med. 2024 Apr;30(1):24-36. doi: 10.6118/jmm.24006. J Menopausal Med. 2024. PMID: 38714491 Free PMC article. Review.
-
Androgen deficiency in hypopituitary women: its consequences and management.Rev Endocr Metab Disord. 2024 Jun;25(3):479-488. doi: 10.1007/s11154-024-09873-1. Epub 2024 Jan 19. Rev Endocr Metab Disord. 2024. PMID: 38240912 Free PMC article. Review.
-
Sexual function in women with polycystic ovary syndrome: a systematic review and meta-analysis.Hum Reprod Update. 2024 May 2;30(3):323-340. doi: 10.1093/humupd/dmad034. Hum Reprod Update. 2024. PMID: 38237144 Free PMC article.
-
The Impact of Testosterone Therapy on Cardiovascular Risk Among Postmenopausal Women.J Endocr Soc. 2023 Oct 25;8(1):bvad132. doi: 10.1210/jendso/bvad132. eCollection 2023 Dec 1. J Endocr Soc. 2023. PMID: 38178905 Free PMC article. Review.
-
Associations Between Blood Concentrations of Sex Hormones and Physical Function in Community-Dwelling Older Women: A Prospective Cohort Study.J Gerontol A Biol Sci Med Sci. 2024 Apr 1;79(4):glad287. doi: 10.1093/gerona/glad287. J Gerontol A Biol Sci Med Sci. 2024. PMID: 38157294 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials